首页> 外文期刊>Anesthesiology >Volatile anesthetic preconditioning present in the invertebrate Caenorhabditis elegans.
【24h】

Volatile anesthetic preconditioning present in the invertebrate Caenorhabditis elegans.

机译:无脊椎动物秀丽隐杆线虫中存在挥发性麻醉剂预处理。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Volatile anesthetics (VAs) have been found to induce a delayed protective response called preconditioning to subsequent hypoxic/ischemic injury. VA preconditioning has been primarily studied in canine and rodent heart. A more genetically tractable model of VA preconditioning would be extremely useful. Here, the authors report the development of the nematode Caenorhabditis elegans as a model of VA preconditioning. METHODS: Wild-type and mutant C. elegans were exposed to isoflurane, halothane, or air under otherwise identical conditions. After varying recovery periods, the animals were challenged with hypoxic, azide, or hyperthermic incubations. After recovery from these incubations, mortality was scored. RESULTS: Isoflurane- and halothane-preconditioned animals had significantly reduced mortality to all three types of injuries compared with air controls. Concentrations as low as 1 vol% isoflurane (0.64 mm) and halothane (0.71 mm) induced significant protection. The onset and duration of protection after anesthetic were 6 and 9 h, respectively. A mutation that blocks inhibition of neurotransmitter release by isoflurane did not attenuate the preconditioning effect. A loss-of-function mutation of the Apaf-1 homolog CED-4 blocked the preconditioning effect of isoflurane, but mutation of the downstream caspase CED-3 did not. CONCLUSIONS: Volatile anesthetic preconditioning extends beyond the vertebrate subphylum. This markedly broadens the scope of VA preconditioning and suggests that its mechanisms are widespread across species and is a fundamental and evolutionarily conserved cellular response. C. elegans offers a means to dissect genetically the mechanism for VA preconditioning as illustrated by the novel finding of the requirement for the Apaf-1 homolog CED-4.
机译:背景:已发现挥发性麻醉药(VAs)会引起对随后的缺氧/缺血性损伤的延迟保护性反应,称为预处理。 VA预处理已经在犬和啮齿动物的心脏中进行了初步研究。 VA预处理的更具遗传易处理性的模型将非常有用。在这里,作者报告了线虫秀丽隐杆线虫的发展作为VA预处理的模型。方法:野生型和突变型秀丽隐杆线虫在其他相同条件下暴露于异氟烷,氟烷或空气中。在不同的恢复期后,对动物进行低氧,叠氮化或高热培养。从这些孵育中恢复后,对死亡率进行评分。结果:异氟烷和氟烷预处理的动物与空气对照组相比,所有三种伤害的死亡率均显着降低。异氟醚(0.64 mm)和氟烷(0.71 mm)的浓度低至1%(体积)可产生明显的保护作用。麻醉后开始保护的时间为6 h,持续时间为9 h。阻止异氟烷抑制神经递质释放的突变不会减弱预处理作用。 Apaf-1同系物CED-4的功能丧失突变阻止了异氟烷的预处理作用,但下游caspase CED-3的突变却没有。结论:挥发性麻醉剂的预处理范围超出了脊椎动物亚门。这显着拓宽了VA预处理的范围,并表明其机理在物种间广泛分布,是一种基本且进化上保守的细胞反应。秀丽隐杆线虫提供了一种从遗传上解剖VA预处理机制的手段,正如对Apaf-1同源CED-4的需求的新颖发现所说明的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号